Physician profile
Katheryn E Strichik
NPI 1437852779
$807.75
in general payments reported to CMS, 2019-2025
17 companies · $808 in 2025
The $808 reported for 2025 was more than what 76% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $177.80 | 2025 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $103.52 | 2025 | Caplyta |
| Acadia Pharmaceuticals INC | $63.03 | 2025 | Nuplazid |
| Axsome Therapeutics, INC. | $50.81 | 2025 | Auvelity |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $46.38 | 2025 | Rejoyn |
| Alexion Pharmaceuticals, INC. | $45.86 | 2025 | Ultomiris |
| Vanda Pharmaceuticals INC. | $45.30 | 2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $42.16 | 2025 | Hyqvia |
| Janssen Pharmaceuticals, INC | $38.60 | 2025 | Spravato |
| Sk Life Science, INC. | $33.91 | 2025 | |
| Ucb, INC. | $30.57 | 2025 | Briviact |
| Merz Pharmaceuticals, LLC | $30.41 | 2025 | Inbrija, Ampyra, Xeomin |
| Janssen Biotech, INC. | $27.61 | 2025 | |
| Tris Pharma INC | $21.17 | 2025 | Dyanavel Xr |
| Neurelis, INC. | $17.58 | 2025 | Valtoco |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $17.12 | 2025 | |
| Abbvie INC. | $15.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katheryn Strichik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.